1-2 of 2
Keywords: Therapeutic drug monitoring
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Real-World Comparison of Drug Trough Levels between Patients Experiencing a Secondary Nonimmune Loss of Response and Those Maintaining a Response to Infliximab on Long-Term Maintenance Therapy for Inflammatory Bowel Disease

Open Access
Subject Area:
Article Collection: Short- and Long-term Real-World Outcomes of Advanced Therapies for Inflammatory Bowel Disease (IBD) , Gastroenterology
Michael Farber, Jeremy Polman, Nina Kohn, Vincent Chua, Arun Swaminath, Keith Sultan
Journal: Inflammatory Intestinal Diseases
Inflamm Intest Dis (2024) 9 (1): 252–259.
https://doi.org/10.1159/000541377
Published Online: 19 September 2024
... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2024 Crohn’s disease Inflammatory bowel disease Loss of response Therapeutic drug monitoring Ulcerative colitis...
View articletitled, A Real-World Comparison of Drug Trough Levels between Patients Experiencing a Secondary Nonimmune Loss of Response and Those Maintaining a Response to Infliximab on Long-Term Maintenance Therapy for Inflammatory Bowel Disease
Open the PDF for A Real-World Comparison of Drug Trough Levels between Patients Experiencing a Secondary Nonimmune Loss of Response and Those Maintaining a Response to Infliximab on Long-Term Maintenance Therapy for Inflammatory Bowel Disease in another window
Journal Articles

Proactive versus Reactive Therapeutic Drug Monitoring: Why, When, and How?

Open Access
Subject Area:
Gastroenterology
Manar Shmais, Miguel Regueiro, Jana G. Hashash
Journal: Inflammatory Intestinal Diseases
Inflamm Intest Dis (2022) 7 (1): 50–58.
https://doi.org/10.1159/000518755
Published Online: 06 September 2021
.... Summary: In this article, we discuss the updated guidelines on TDM and will also discuss the available data supporting proactive and reactive TDM in patients with Crohn’s disease and those with ulcerative colitis using the different available biological agents. Key Messages: Therapeutic drug monitoring...
View articletitled, Proactive versus Reactive Therapeutic Drug Monitoring: Why, When, and How?
Open the PDF for Proactive versus Reactive Therapeutic Drug Monitoring: Why, When, and How? in another window